BI
BPMC

BVF Inc’s Blueprint Medicines BPMC Stock Holding History

BVF Inc’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-183,834
Closed -$14.7M – 58
2019
Q4 		$14.7M Sell
183,834
-253,731
-58% -$19M 1.12% 23
2019
Q3 		$32.1M Hold
437,565
– – 3.38% 9
2019
Q2 		$41.3M Sell
437,565
-127,400
-23% -$10.5M 4.51% 7
2019
Q1 		$45.2M Sell
564,965
-10,002
-2% -$739K 5.06% 3
2018
Q4 		$31M Sell
574,967
-23,300
-4% -$1.42M 4.05% 5
2018
Q3 		$46.7M Sell
598,267
-48,544
-8% -$3.37M 4.1% 6
2018
Q2 		$41.1M Sell
646,811
-8,800
-1% -$700K 4.01% 6
2018
Q1 		$60.1M Sell
655,611
-111,743
-15% -$9.63M 6.09% 4
2017
Q4 		$57.9M Sell
767,354
-240,000
-24% -$16.9M 6.98% 3
2017
Q3 		$70.2M Sell
1,007,354
-584,292
-37% -$31.2M 8.92% 2
2017
Q2 		$80.6M Sell
1,591,646
-510,634
-24% -$21.7M 12.52% 1
2017
Q1 		$84.1M Sell
2,102,280
-1,153,000
-35% -$41.3M 14.3% 1
2016
Q4 		$91.3M Buy
3,255,280
+490,200
+18% +$14.8M 18.35% 1
2016
Q3 		$82.1M Sell
2,765,080
-130,171
-4% -$3.23M 15.48% 1
2016
Q2 		$58.6M Buy
2,895,251
+255,000
+10% +$4.63M 12.49% 1
2016
Q1 		$47.7M Buy
2,640,251
+361,792
+16% +$6.28M 11.79% 1
2015
Q4 		$60M Buy
2,278,459
+575,805
+34% +$13M 10.23% 1
2015
Q3 		$36.3M Buy
1,702,654
+120,246
+8% +$3.33M 7.34% 6
2015
Q2 		$41.9M Buy
+1,582,408
New +$45.2M 7.4% 3

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc's BPMC Position: Q1 2020 in Review

BVF Inc sold out of Blueprint Medicines (BPMC) in Q1 2020, closing a stake of 183,834 shares — an estimated $14.7M sold.

BVF Inc first reported a position in BPMC in Q2 2015 and held it in 19 quarters. The position peaked at $91.3M in Q4 2016. 213 funds tracked by Wall St. Rank hold BPMC as of Q1 2020.

  • BVF Inc reported no remaining Blueprint Medicines position as of Q1 2020 after selling out during the quarter.
  • BVF Inc sold 183,834 Blueprint Medicines shares in Q1 2020, an estimated $14.7M.
  • BVF Inc first reported a position in Blueprint Medicines in Q2 2015 and held it in 19 quarters.
  • BVF Inc's Blueprint Medicines position peaked at $91.3M in Q4 2016.
  • 213 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2020.

Based on BVF Inc's 13F filing for Q1 2020, filed 15 May 2020.